Hospital News and Research

RSS

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

20 Oct 2009

UHC selects RGIS to streamline inventory counting services

The University HealthSystem Consortium (UHC) today announced that it has awarded a 3-year agreement to RGIS, based in Auburn Hills, Mich, for inventory counting services. The agreement, which has 2 automatic 1-year renewal periods, became effective on September 1, 2009.

20 Oct 2009

OrSense presents data on its NBM-200MP system for hemoglobin and blood oximetry measurements

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the American Association of Anesthesiologists (ASA) annual meeting, in New Orleans. The results from a multi-center study indicate that NBM-200MP, a continuous, non-invasive monitoring system, measures levels of oxygen saturation and hemoglobin accurately and reliably in comparison to accepted methods.

20 Oct 2009

Poor readiness by many hospitals to tackle H1N1 pandemic; RNs step up protest

Some 16,000 registered nurses at 39 hospitals at three Catholic hospital chains in California and Nevada will join a one-day strike and picket October 30 as RNs step up the protest over poor readiness by many hospitals to confront the H1N1 pandemic, the California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) announced today.

20 Oct 2009

Optimer Pharmaceuticals to present additional data on fidaxomicin at the 47th IDSA meeting

Optimer Pharmaceuticals, Inc. announced that additional data related to fidaxomicin, the Company's lead developmental product candidate for the treatment of Clostridium difficile infection, will be presented at the 47th Annual Meeting of the Infectious Disease Society of America (IDSA) to be held at The Philadelphia Convention Center in Philadelphia, Pennsylvania October 29 through November 1, 2009.

20 Oct 2009

Jennerex' JX-594 granted European Orphan Drug Designation for the treatment of hepatocellular carcinoma

Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.

20 Oct 2009

Third-quarter financial results of Boston Scientific announced

Boston Scientific Corporation today announced financial results for the third quarter ended September 30, 2009, as well as guidance for net sales and earnings per share (EPS) for the fourth quarter and full year 2009.

20 Oct 2009

Lawmakers struggle to balance interests as sweeping health legislation negotiations proceed

Lawmakers continue to try to shape health bills as they move closer to floor votes.

20 Oct 2009

Positive results from Transave's Phase II ARIKACE clinical trials

Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections.

20 Oct 2009

Article evaluating StemEx therapy for leukemia and lymphoma to be published

Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma.

19 Oct 2009

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB today announced data that showed rapid and sustained improvements in ACR20, physical function, pain and fatigue of rheumatoid arthritis (RA) as early as the first week, and inhibition of progression of structural joint damage (seen at week 24) following treatment with Cimzia (certolizumab pegol), together with methotrexate (MTX), was sustained up to 100 weeks.

19 Oct 2009

Scientists find cause for lupuslike disease in mice

Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease.

19 Oct 2009

California's community hospitals launch public education and media campaign on H1N1

As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.

19 Oct 2009

Baxa and SINOPHARM sign distribution agreement

Baxa Corporation, a US-based medical device company in Englewood, Colorado, has signed an exclusive four-year distribution agreement with SINOPHARM, a China National Pharmaceutical Foreign Trade Corporation, to promote sales of its products in China.

19 Oct 2009

Even with budget concerns, lawmakers fight for rural hospitals

Kaiser Health News' staff writers Eric Pianin and Mary Agnes Carey report in a story produced in collaboration with Politico on rural hospitals' stake in the ongoing efforts to overhaul the nation's health system.

19 Oct 2009

Study on the economic impact of antibiotic overuse and antibiotic-resistant infections

The Alliance for the Prudent Use of Antibiotics (APUA) and Cook County Hospital (currently John H. Stroger, Jr. Hospital of Cook County), today announced the release of an eye-opening study on the economic impact of antibiotic overuse and antibiotic-resistant infections (ARIs) sponsored by an unrestricted educational grant from bioMerieux and the Centers for Disease Control and Prevention (CDC).

19 Oct 2009

Health providers make cuts, changes and gambles in face-off with economy

News reports this weekend highlight several developments as medical providers respond to changing economic forces, and in some cases, clashes of personality.

19 Oct 2009

Merge Healthcare to launch new anesthesia information management solutions at ASA 2009 Annual Meeting

As increased regulatory compliance and pay-for-performance models are leading to higher requirements for electronic data collection and professional fee billing of surgery-related procedures, Merge Healthcare, has responded with new anesthesia information management solutions (AIMS), which will be on display at the American Society of Anesthesiologists (ASA) 2009 Annual Meeting.

19 Oct 2009

Medicaid expansion could hit struggling state budgets

"The government programs that provide health care to the poor would expand to cover nearly one in five Americans under health insurance legislation pending in Congress, putting pressure on federal and state budgets," USA Today reports.

19 Oct 2009

Apollo Medical Holdings completes sale of convertible notes and warrants of value $1.25M

Apollo Medical Holdings, Inc., a leading provider of management services to medical groups that provide comprehensive hospital-based medical services, today announced that it has completed the sale of convertible notes and warrants through a private placement offering.

19 Oct 2009

Hospital News and Research

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

UHC selects RGIS to streamline inventory counting services

OrSense presents data on its NBM-200MP system for hemoglobin and blood oximetry measurements

Poor readiness by many hospitals to tackle H1N1 pandemic; RNs step up protest

Optimer Pharmaceuticals to present additional data on fidaxomicin at the 47th IDSA meeting

Jennerex' JX-594 granted European Orphan Drug Designation for the treatment of hepatocellular carcinoma

Third-quarter financial results of Boston Scientific announced

Lawmakers struggle to balance interests as sweeping health legislation negotiations proceed

Positive results from Transave's Phase II ARIKACE clinical trials

Article evaluating StemEx therapy for leukemia and lymphoma to be published

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Scientists find cause for lupuslike disease in mice

California's community hospitals launch public education and media campaign on H1N1

Baxa and SINOPHARM sign distribution agreement

Even with budget concerns, lawmakers fight for rural hospitals

Study on the economic impact of antibiotic overuse and antibiotic-resistant infections

Health providers make cuts, changes and gambles in face-off with economy

Merge Healthcare to launch new anesthesia information management solutions at ASA 2009 Annual Meeting

Medicaid expansion could hit struggling state budgets

Apollo Medical Holdings completes sale of convertible notes and warrants of value $1.25M

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News